JONATHAN D. CHRISTENBURY, M.D., F.A.C.S. CURRICULUM VITAE. OFFICE TELEPHONE FAX

Transcription

1 CURRENT POSITION OFFICE ADDRESS Medical Director / President & Chief Executive Officer Christenbury Eye Center 3621 Randolph Road Suite 100 Charlotte, NC OFFICE TELEPHONE FAX drc@christenbury.com EDUCATION B.S. Biology / Chemistry Oral Roberts University Tulsa, OK M.D. Duke University School of Medicine Durham, NC Resident in Anesthesia Duke University Hospital Internship, Internal Medicine Baylor College of Medicine Residency, Ophthalmology Duke University Eye Center Locum Tenens in Ophthalmology Barr Eye Center Durham, NC Houston, TX Durham, NC Stockton, CA Fellowship, Ophthalmic Plastic and Orbital Surgery Jules Stein Eye Institute, UCLA Los Angeles, CA EMPLOYMENT Christenbury Eye Center Jonathan D. Christenbury, M.D., P.A. Private Practice Present

2 ORGANIZATIONS American College of Surgeons American Medical Association American Academy of Ophthalmology North Carolina Medical Society Mecklenburg County Medical Association American Board of Eye Surgeons North Carolina Society of Eye Physicians and Surgeons European Society of Refractive Surgeons International Society of Refractive Surgery American Society of Cataract and Refractive Surgery American Society of Ophthalmic Plastic & Reconstructive Surgery International Society of Bilateral Cataract Surgeons North Carolina Chapter, American College of Surgeons American College of Ophthalmic Surgery HONORS AND AWARDS Graduated from Oral Roberts University Summa Cum Laude Diplomat of American Academy of Ophthalmic Plastic and Reconstructive Surgery Board Certified by American Board of Ophthalmology (October 11, 1986) Fellow, American College of Surgeons Intralase World s most experienced IntraLASIK Surgeon 2002 Intralase Pioneer Award November 2003 American Academy of Ophthalmology Achievement Award May 2004 CLINICAL TRIALS FDA Chief Investigator, clinical study Technolas Excimer Laser 1994 to 2003 PRK & LASIK MEDICAL / SURGICAL PRIVILEGES Presbyterian Hospital Charlotte, NC Mercy Hospital Charlotte, NC Carolinas Medical Center Charlotte, NC Associate Classification Carolinas Surgery Center Charlotte, NC AREAS OF SPECIALTY Ophthalmology Ophthalmic Plastic Surgery Refractive Surgery Laser Vision Correction

3 MEDICAL LICENSES North Carolina (issued 08/01/96) - # South Carolina - # Virginia - # California (issued 09/26/85) - #G Alabama - #18676 DEA - #AC OTHER CERTIFICATIONS Bausch and Lomb C-LASIK Bausch and Lomb 217 Laser - 11/2000 Bausch and Lomb Zyoptix - Nidek Laser System - 01/2000 VISX Excimer Laser System - 06/2001 LSX Laser System - 02/2001 IntraLASIK - 01/2002 Ladar Wave Custom Cornea Ladar - MediSurg R&MC Fugo Blade - 01/2003 VISX Physician CustomVue Certification Course - 06/2003 Conductive Keratpolasty (CK) - 07/2003 Visian ICL (Staar Surgical) - 09/2003 Thermacol/Thermage TC System - 02/2004 Eyeonics Cyrstalens - 05/2004 Verisyse - 07/2004 Allegreto Wave Excimer Laser - 08/2004 Intacs MD - 10/2004 VISX CustomVue - 01/2005 Apodized Diffractive IOL - 04/2005 VISX CustomVue High Myopia - 01/2006 VISX CustomVue Hyper Astigm - 01/2006 Ladar 6000 Excimer Laser - 08/2006 VISX CustomVue Mono/Presby - 04/2008 Zeiss Visumax - 01/2012 IEK-Intralase Enabled Keratoplasty - 10/2012 ADVISORY BOARD MEMBERSHIPS Austin Medical Technologies, Inc ARTICLES / PUBLICATIONS / CLASSES TAUGHT American Academy of Ophthalmology 1997

4 Endoscopic Browlift, Proctor American Academy of Ophthalmology 1998 Endoscopic Browlift, Proctor Total Choroidal Detachment Complicating Dural Arteriovenous Sinus Fistula Ophthalmic Surgery December 1993 Translacrimal Laser Dacryocystorhinostomy Archive of Ophthalmology February 1992 Use of Proplast II Ophthalmic Plastic and Reconstructive Surgery 1991 Blindness Following Blepharoplasty: Two Case Reports, and A Discussion of Management Ophthalmic Surgery February 1990 Medical Entroption Following Orbital Decompression for Dysthyroid Ophthalmopathy Ophthalmic Plastic and Reconstructive Surgery 1988 Free Autogenous Pearl Fat Grafts to the Eyelid Ophthalmic Plastic and Reconstructive Surgery 1988 Management of Ptosis in Chronic Progressive External Ophthalmoplegia Ophthalmic Plastic and Reconstructive Surgery 1987 Tarsojunctival Grafts for Upper Eyelid Cicatrical Entropion Ophthalmic Surgery May 1988 A New Lacrimal Scissors Ophthalmic Surgery July 1987 A Complication Using A Crawford Hook Archive of Ophthalmology June 1987 Potential Acuity Meter for Predicting Postoperative Visual Acuity in Cataract Patients American Journal of Ophthalmology March 1985 Neurilemmoma of the Frontal-ethmoid Sinus Stimulating a Mucocele. A Case Report Journal of Clinical Neuroophthalmology December 1984

5 CLINICAL TRIALS PROTOCOL EXCM-650-MYO February 4, 1997 December 20, 1997 A Phase III Prospective Multicenter Clinical Trial to Evaluate the Safety and Effectiveness of the Chiron Technolas KERACOR 116 Excimer Laser for the Correction of Mild Myopia PROTOCOL EXCM-622-RET February 11, 1997 December 20, 1997 A Protocol for the Retreatment of Eyes with Undercorrected Refractive Error Following Photorefractive Keratectomy or LASIK Originally Performed with the Chiron Technolas KERACOR 116 Excimer Laser under a Phase II Investigational Protocol. PROTOCOL EXCM-623-RET February 13, 1997 December 20, 1997 A Protocol for the Retreatment of Eyes with Undercorrected Refractive Error Following Photorefractive Keratectomy originally performed with the Chiron Technolas KERACOR 116 Excimer Laser under Protocol EXCM-650- MYO or EXCM-651-FEL. PROTOCOL EXCM-651-FEL February 20, 1997 December 20, 1997 A Phase III Prospective Multi-center Clinical Trial to Evaluate the Safety of the Chiron Technolas KERACOR 116 Excimer Laser for the Correction of Mild Myopia and Astigmatism in Fellow Eyes of Subjects Initially Treated Under Protocol EXCM-650-MYO. PROTOCOL EXKM-604-AST March 25, 1997 September 9, 1998 A Prospective Multi-center Clinical Trial to Evaluate the Safety and Effectiveness of the Chiron Technolas KERACOR Excimer Laser When Used For Intrastromal Ablation (LASIK or Laser in Situ Keratomileusis) for the Correction of D of Myopia with up to 5.0D of Astigmatism. PROTOCOL EXKM-603-MYO July 7, 1997 December 20, 1997 A Phase III Prospective Randomized Controlled Multi-center Clinical Trial to Compare Surgical Correction of Myopia with Excimer Laser Photorefractive Keratectomy versus Laser in Situ Keratomileusis. PROTOCOL G August 25, 1998 May 27, 1999 A Physician Sponsored Prospective Single Center Clinical Trial to Evaluate the Safety and Effectiveness of the Chiron Technolas KERACOR 116 Excimer Laser System, Used for Intrastromal Ablation (LASIK, or Laser In Situ Keratomileusis) for the Correction of 0.75D to 12.0D of Myopia, With or Without 0.50D to 5.0D of Astigmatism with 800 Patients Alternatively Divided Between the Standard Pre-Treatment and Treatment Nomogram and the International Pre-Treatment and Treatment Nomogram.

6 PROTOCOL EXKM-609-AST March 18, 1999 November 30, 2000 A Prospective, Multi-center Clinical Trial to Evaluate the Safety and Effectiveness of the Technolas 217A Excimer Laser When Used for Intrastromal Ablation (LASIK, or Laser In Situ Keratomileusis) for the Correction of D of Myopia with 0.50 to 5.00 D of Astigmatism. PROTOCOL EXKM-607-HYP May 5, 1999 April 8, 2002 A Prospective Multi-center Clinical Trial to Evaluate the Safety and Effectiveness of the Technolas 217A Excimer Laser when used for Intrastromal Ablation (LASIK, or Laser In Situ Keratomileusis) for the Correction of Naturally Occurring Hyperopia between D of Spherical Refraction with No More Than 0.50 D of Refractive Astigmatism PROTOCOL G September 4, 1997 August 25, 1998 Chiron Technolas KERACOR 116 Excimer Laser System Indication for Use: A Physician Sponsored Laser in Situ Keratomileusis (LASIK) Treatment for the Correction of Myopia 0.75 to Diopter (D) With or Without Astigmatism 0.50 to 5.00 D who will be assigned to 130 microns, 160 microns, or 180 microns corneal cuts PROTOCOL G970172/S12 May 26, 1999 December 28, 1999 Chiron Technolas KERACOR 116 Excimer Laser System Indication for Use: A Physician Sponsored Laser in Situ Keratomileusis (LASIK) Treatment for the Correction of Myopia 0.75 to Diopter (D) With or Without Astigmatism 0.50 to 5.00 D in Subjects 18 to 20 Years of Age Adolescent Study. PROTOCOL G May 17, 1999 May 2, 2003 Chiron Technolas KERACOR 116 Excimer Laser System Indication for Use: A Physician Sponsored Prospective Single Center Clinical Trial to Evaluate the Safety and Effectiveness of the Chiron Technolas Keracor 116 Excimer Laser System, Used for Intrastromal Ablation (LASIK, or Laser In Situ Keratomileusis) for the Correction of 0.75D to 12.0D of Myopia, With or Without 0.50D to 5.0D of Astigmatism with 800 Patients Alternatively Divided Between the Standard Pre-Treatment and Treatment Nomogram and the International Pre-Treatment and Treatment Nomogram. PROTOCOL NE91 April 25, 2001 August, 2003 Nidek EC-5000 Excimer Laser System A Prospective, Multi-center Clinical Trail to Evaluate the Safety and Effectiveness of the 193 nm Nidek EC-5000 Excimer Laser System When Used for Hyperopic Laser Assisted In Situ Keratomileusis (H-LASIK) for the Correction of Up To and Inculding +6.0 Diopter (D) Manifest Refraction

7 Spherical Equivalent (S.E. or MRSE) with Up To and Including 4.0 D of Astigmatism and Up To and Including 6.0 D of Mixed Astigmatism.